TR EN AR RU KK

SSAB_ASSAB

Materials
NORDIC
94.00
EUR
Analysis Scores
Lothien Robustness Score?
50/100
Moderate
Neden bu skor?
Damodaran ?
31/100
Dalio Risk ?
93/100
Piotroski ?
4/9
Neutral
Previous period ROA data missing (C1 delta-ROA); Previous year data missing → margin comparison unavailable (C8)
Graham ?
€8.6
Pahalı
Active Metric?
4/4
Confidence?
75%
Lothien Robustness Summary
70/100
Lothien Sağlamlık: Güçlü (70/100)
Genel tablo olumlu. Finansal yapı sağlam, bazı riskler mevcut. | Kısa Vade: Olumlu | Uzun Vade: Nötr | Pozitif: 6 | Negatif: 2 | Nötr: 1
Net Kâr Pozitif
Son çeyrekte €183M net kâr açıklandı. Şirket kârlı.
Çeyreklik Kâr Artışı
Net kâr bir önceki çeyreğe göre %+30.0 arttı (€141M → €183M). Kısa vadede olumlu momentum.
4 Çeyrek Üst Üste Artış
Son 4 çeyrek üst üste kâr artıyor. Güçlü yukarı trend devam ediyor.
Net Nakit Pozisyonu
Şirketin nakdi borçlarından €775M fazla. Borç riski düşük.
Güçlü Likidite
Cari oran 2.42x — kısa vadeli borçları rahat karşılıyor.
Güçlü Nakit Üretimi
Serbest nakit akışı (€166M) kârın %90'sini nakit olarak üretiyor. Kâr kalitesi yüksek.
Yüksek F/K Uyarısı
Trailing F/K: 100.0. Piyasa yüksek büyüme bekliyor ya da hisse pahalı. Büyüme gerçekleşmezse düşüş riski yüksek.
Yüksek PD/DD
PD/DD: 15.03. Piyasa defter değerinin çok üstünde fiyatlıyor. Büyüme beklentisi primli.
Yüksek EV/EBITDA
EV/EBITDA: 89.0. Pahalı değerleme.

Data date 2026-11-10 Not investment advice; the figures are rule-based model output. How the scores are computed

Score record
Method How the scores are computed · Scorecard
Data date 2026-11-10
Update frequency Scheduled analysis run on business days at 19:30 Istanbul time; not every symbol is refreshed in every run

Method summaryThe Lothien Robustness Score (0-100) is a weighted combination of sub-scores computed by fixed rules from published financial statements and price data (Damodaran valuation, Dalio risk, Piotroski F-score, earnings quality, momentum and others). The rules are applied automatically to every covered stock, with weights that vary by sector.

AssumptionsCalculations rest on the company's latest published financial statements and on price data that may be delayed. Where four quarters have not been published, annual figures may be scaled from the available quarters. Model parameters such as the risk-free rate, the risk premium and long-term growth are fixed assumptions per exchange and contain no company-specific expectation.

Conflict of interestNo statement has been published on whether MIDAK, the operator of Lothien, or its team hold positions in these stocks. The figures are produced automatically by the same rules, without regard to any such position.

WarningThis information is not within the scope of investment advisory services and is not investment advice. The figures are the output of rule-based models and may not suit your financial situation or your risk and return preferences. Making an investment decision on the basis of this information alone may not lead to results that meet your expectations.

Model output; not investment advice; different models can disagree. Report an error

Risk Analysis (VaR) Yüksek
252 days
Annual Volatility ?
%35.5
VaR 95% ?
%3.49
daily max loss
VaR 99% ?
%5.02
daily max loss
CVaR 95% ?
%4.63
expected loss (tail)
Max Drawdown ?
%16.8
11.02.2026 → 19.03.2026
Skewness ?
-0.11
Parametrik%3.49
Historik%3.48
Cornish-Fisher%3.51
Return Distribution
Valuation
Potential?
-32.1%
ROIC ?
12.2%
DCF Value ?
13.16
Debt Cycle?
Early Expansion
Balance Sheet Analysis? Q2026/9
Son 6 çeyrek ardışık kâr
Fiyat TRAMA-99 altında: %-5.9 — teknik trend olumsuz
Direnç seviyesi: TRAMA-99 = 99.94 EUR
Fundamental & Technical Analysis
Profitability
Net Profit Margin %7.6
Net profit margin %7.6 — positive but low. Compared to previous quarter +1.3 point increase.
ROE - Return on Equity (TTM) %5.8
ROE %5.8 — low return on equity.
EBITDA Margin %13.6
EBITDA margin %13.6 — moderate operational efficiency.
Gross Profit Margin %15.6
Gross profit per revenue %15.6. Evaluate relative to sector.
Free Cash Flow Margin (TTM) %-1.5
TTM Free Cash Flow is %-1.5'i. Negative FCF — company consuming cash.
Valuation
P/E Ratio 100.0x Sector: 82.5x
F/K 100.0x — sector median's (82.5x) %21 above. Slight premium.
P/B Ratio 15.03x Sector: 10.09x
PD/DD 15.03x — sector median's (10.09x) %49 above.
EV/EBITDA 89.0x Sector: 72.8x
EV/EBITDA 89.0x — sector median's (72.8x) %22 above. Expensive relative to EBITDA.
Indebtedness
Current Ratio 2.42x
Current ratio 2.42x — current assets are 2x short-term liabilities. Very healthy liquidity.
Net Debt / EBITDA 0.9x
Net Debt/EBITDA 0.9x — very low debt burden. Company can repay debt quickly.
Debt / Equity 0.15x
Low leverage — majority of assets financed by equity.
Interest Coverage 20.2x
Interest coverage 20.2x — very wide margin for paying interest expenses.
Growth
Revenue Growth (YoY) %+7.2
Revenue YoY %7.2 grew — positive but slow growth.
Net Profit Growth (YoY) %+12.2
Net profit YoY %12.2 increased — positive but moderate growth.
Score Explanations
Lothien Robustness
50/100
Moderate robustness (50/100). Valuation and risk criteria give mixed signals. Detailed review recommended.
Moderate
Potential
-32.1%
Minus %32.1 expected value (63.80) vs current price comparison. 4/4 valuation models could be calculated. Model confidence %75.
Components: PE target: 45.16 | P/B target: 64.98 | EV/EBITDA target: 76.93 | DCF target: 23.50
Damodaran Valuation
31/100
Low Damodaran score (31/100). DCF analysis does not support current price.
Weak
Dalio Risk Analysis
93/100
Low debt risk (93/100). Interest coverage ratio 20.2x — strong. Debt/EBITDA 0.9x — in healthy range.
Leverage: 92/100 | Debt Service: 100/100 | Quality: 74/100
ROIC - Return on Capital
%12.2
ROIC (%12.2) slightly exceeds cost of capital (2.8 points).
WACC: %9.4
DCF Discounted Cash Flow
13.16
DCF (13.16) current price %86.0 below — cash flows do not support current price.
Current price: 94.00
Debt Cycle Phase
Early Expansion
Debt decreasing, growth gaining momentum. Company in balance sheet cleanup phase.
Piotroski F-Score
4/9
Weak Piotroski (4/9). Many balance sheet quality criteria not met. Note: Previous period ROA data missing (C1 delta-ROA); Previous year data missing → margin comparison unavailable (C8)
Neutral
Graham Intrinsic Value
€8.6
Expensive
⚖️ Sector Comparison
P/E Ratio
100.0x vs 82.5x
Sector median's %21 above — expensive
P/B Ratio
15.03x vs 10.09x
Compared to sector %49 more expensive (by book value)
EV/EBITDA
89.0x vs 72.8x
Compared to sector %22 higher EV/EBITDA
ROIC vs WACC
%12.2 vs %9.4 WACC
ROIC 2.8 bps above cost of capital
Net Profit Margin (TTM)
%5.9 vs %11.8 EBITDA margin
TTM net profit margin %5.9
TRAMA-99 Trend — Downtrend
Price (94.00), TRAMA-99 line's %5.9 below. Downtrend ongoing — technical outlook negative. Pressure may continue until TRAMA is broken above.
Price:: 94.00
TRAMA: 99.94
Difference: %-5.9
Charts
Indicators
BB deviation ?
RSI thresholds ?

Price Chart ?
RSI (14) ?
Bollinger Bands ?
MACD ?
Gold-Based Price + TRAMA (Stock / Gram Gold) ?
P/E Ratio ?
P/B Ratio ?
EBITDA ?
Net Working Capital ?
Current Ratio ?
SSAB_A — Participation Finance Compliance
Loading…
The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.